|1|MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver. (24383923)
Jiang M.... Schlaak J.F.
|2|Hepatocyte Nuclear Factor 4I+ and Downstream Secreted Phospholipase A2 GXIIB Regulate Production of Infectious Hepatitis C Virus. (24173221)
Li X.... Peng T.
|3|How to optimize current treatment of genotype 2 hepatitis C virus infection. (24373073)
Marciano S.... Gadano A.C.
|4|Septic bursitis, a potential complication of protease inhibitor use in hepatitis C virus. (23413416)
Burke C.C.... Dieterich D.T.
|5|Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T-cells in immune-primed chimpanzees. (24123114)
Zubkova I.... Major M.
|6|Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems. (24112091)
Fuster D.... Tsui J.I.
|7|Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. (24270546)
Park S.H.... Rehermann B.
|8|Activation of the connective tissue growth factor (CTGF)-transforming growth factor I^ 1 (TGF-I^ 1) axis in hepatitis C virus-expressing hepatocytes. (23056332)
Nagaraja T.... Ganju R.K.
|9|A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. (22729936)
Liu W.... Wu J.L.
|10|MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles. (22911431)
Menzel N.... Pietschmann T.
|11|Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1I+. (22993150)
Matsui C.... Hotta H.
|12|Differential stimulation of hepatitis C virus RNA translation by microRNA-122 in different cell cycle phases. (22189820)
Fehr C.... Niepmann M.
|13|Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. (21402922)
Dring M.M.... Gardiner C.M.
|14|HLA-C/KIR genotypes in oral lichen planus patients infected or non-infected with hepatitis C virus. (20860769)
Carrozzo M.... Amoroso A.
|15|Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus. (21618576)
Hiraga N.... Chayama K.
|16|Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus. (21480314)
Peng Z.G.... Jiang J.D.
|17|Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. (21282107)
Tacke R.S.... Hahn Y.S.
|18|Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virus. (22355520)
Ray U.... Das S.
|19|The ESCRT system is required for hepatitis C virus production. (21264300)
Ariumi Y.... Kato N.
|20|IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. (21931540)
Suppiah V.... Booth D.R.
|21|Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al. (20131242)
De Vita S.... Quartuccio L.
|22|Aortic dissection caused by aortitis associated with hepatitis C virus-related cryoglobulinemia. (20728096)
Fukunaga N.... Okada Y.
|23|Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase. (20534540)
Mankouri J.... Harris M.
|24|Evaluation of the role of three candidate human kinases in the conversion of the hepatitis C virus inhibitor 2'-C-methyl-cytidine to its 5'-monophosphate metabolite. (19883694)
Golitsina N.L.... Standring D.N.
|25|The role of P-glycoprotein in the pharmacokinetics and tissue distribution of a hepatitis C virus protease inhibitor. (19995330)
Chen K.X.... Cheng K.C.
|26|Hepatitis C virus receptor expression in normal and diseased liver tissue. (18085708)
Reynolds G.M.... McKeating J.A.
|27|Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-L. (18474223)
Yeh C.T.... Cheng J.C.
|28|A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action. (18341617)
MacDonald A.J.... Rosenberg W.M.
|29|Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk. (18420802)
Inubushi S.... Hotta H.
|30|Etiologic treatment of hepatitis C virus-associated mixed cryoglobulinemia. (17936209)
Mazzaro C.... Tirelli U.
|31|Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV. (17763328)
Roe B.... Hall W.W.
|32|Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. (17112629)
Aly H.H.... Shimotohno K.
|33|Analysis of mutations within the 5' untranslated region, interferon sensitivity region, and PePHD region as a function of response to interferon therapy in hepatitis C virus-infected patients in India. (16517843)
Gupta R.... Das S.
|34|Interferon-alpha suppresses liver cell proliferation in patients with chronic hepatitis C virus infection. (16108765)
Donato M.F.... Colombo M.
|35|Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. (15611113)
Mazzocca A.... Pinzani M.
|36|Effects of combined antiviral therapy on asymptomatic mixed cryoglobulinemia in naive patients with chronic hepatitis C virus infection: a preliminary study. (16416186)
D'Amico E.... Palazzi C.
|37|Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients. (16062173)
Peffault de Latour R.... SociAc G.
|38|Screening and cloning target genes transactivated by hepatitis C virus F protein using suppression subtractive hybridization technique. (16174453)
Guo J.... Wu S.H.
|39|Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. (16227268)
Hamamoto I.... Matsuura Y.
|40|Structural biology of human CD81, a receptor for hepatitis C virus]. (15449903)
|41|Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3. (15272411)
Theurl I.... Weiss G.
|42|Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. (12500190)
Wang Y.... Omata M.
|43|Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection. (12825172)
Yu M.L.... Chang W.Y.
|44|Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype. (11454804)
Nakano I.... Nakano S.
|45|The amino acid sequence of the PKR-eIF2alpha phosphorylation homology domain of hepatitis C virus envelope 2 protein and response to interferon-alpha. (11023475)
Cochrane A.... McCruden E.A.
|46|Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital. (9375872)
Kerr G.S.... Seeff L.B.
|47|An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. (9307733)
Carrozzo M.... Ghisetti V.
|48|Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. (7541387)
Koizumi K.... Sato C.
|49|Hepatitis C virus associated membranous glomerulonephritis. (8556829)
Stehman-Breen C.... Johnson R.J.
|50|Hepatitis C virus antibody titration in patients with chronic hepatitis C, before and after interferon treatment. (1279945)
Takahashi M.... Tsuji T.